[Commentary on] Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis. Lotan Y, Svatek RS, Sagalowsky AI, Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.
| Publicado en: | Urologic Oncology Vol. 25; no. 3; pp. 274 - 275 |
|---|---|
| Autor principal: | |
| Formato: | abstract commentary Journal Article |
| Publicado: |
Elsevier B.V.
May2007
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105931558&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105931558 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10781439 JJ4 jtl: Urologic Oncology issn: 10781439 maglogo: N pubinfo: dt: May2007 vid: 25 iid: 3 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 105931558 105931558 2009623604 10.1016/j.urolonc.2007.03.009 105931558 ppf: 274 ppct: 1 formats: tig: atl: [Commentary on] Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis. Lotan Y, Svatek RS, Sagalowsky AI, Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX. aug: au: See WA sug: subj: Bladder Neoplasms Risk Factors Bladder Neoplasms Therapy Bladder Neoplasms Diagnosis Cost Control pubtype: Academic Journal doctype: abstract commentary Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|